CARL

Carlsmed, Inc. NASDAQ Listed Apr 5, 2018

Healthcare ·Medical - Healthcare Information Services ·US · carlsmed.com

$11.01

+2.32% vs $10.76

Mkt Cap $156.6M

52w Low $8.83 26.7% of range 52w High $16.99

50d MA $10.23 200d MA $12.45

P/E (TTM) -5.2x

EV/EBITDA —

P/B 1.6x

Debt/Equity 0.2x

ROE -30.0%

P/FCF -5.3x

RSI (14) —

ATR (14) —

Beta 3.66

50d MA $10.23

200d MA $12.45

Avg Volume 140.4K

Carlsmed, Inc. develops and operates a surgical platform for the treatment of complex adult spinal deformities that enables surgeons to harness clinical intelligence, advanced image recognition, and 3D printing technologies. Its product includes aprevo, a medical platform that makes surgical plans and devices tailored to the precise medical situation of every individual patient. It provides New Technology Add-On Payment (NTAP) reimbursement. The company was incorporated in 2018 and is based in Carlsbad, California.

CIK (SEC)

1794546

Phone

(760) 766-1923

1800 Aston Avenue · Carlsbad, CA 92008 · US

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
May 5, 2026	AMC	-0.43	-0.32	+25.6%	8.92	+6.5%	+10.3%	-0.9%	+0.5%	-1.4%	+1.8%	—
Feb 25, 2026	AMC	-0.43	-0.32	+25.6%	12.56	+0.0%	+15.9%	+0.1%	-8.2%	-1.2%	-1.7%	—
Nov 6, 2025	AMC	-0.45	-0.40	+11.1%	11.89	+7.2%	+14.9%	-7.7%	-3.4%	+1.3%	+3.1%	—
Aug 28, 2025	AMC	-1.52	-1.47	+3.3%	13.69	-2.6%	-2.8%	+1.7%	-4.2%	-0.4%	-1.3%	—

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Apr 15	Truist	Maintains	Buy → Buy	—	$10.44	$10.58	+1.3%	+4.9%	-2.5%	+2.8%	-0.4%	-1.7%
Apr 9	Goldman Sachs	Maintains	Buy → Buy	—	$9.99	$9.81	-1.8%	-2.7%	-8.0%	+8.5%	+7.6%	+4.9%
Dec 15	BTIG	Maintains	Buy → Buy	—	$12.95	$13.15	+1.5%	-0.3%	-2.4%	+0.0%	-0.3%	+2.3%
Nov 7	BTIG	Maintains	Buy → Buy	—	$11.89	$12.75	+7.2%	+14.9%	-7.7%	-3.4%	+1.3%	+3.1%
Nov 7	Truist	Maintains	Buy → Buy	—	$11.89	$12.75	+7.2%	+14.9%	-7.7%	-3.4%	+1.3%	+3.1%

Data updated apr 24, 2026 11:52pm · Source: massive.com